| Margins | Restructuring intended for efficient resource utilization. |
|---|---|
| Management confidence | High; aims for independent strategic focus and capital deployment. |
Growth
Shareholders to receive 1 share of MRL for every 3 shares of Health X. Public shareholding in Health X increases to 41.57%.
Outlook
Consolidates healthcare into Health X and financial services into MRL. MRL to be listed on BSE/NSE.
Risks
Restructuring involves NCLT and RBI approvals, with an estimated 12-14 month implementation timeline.
Last quarter's promises, checked
Delivered
- EBITDA break-even Retailer Shakti by Q4 FY26 → delivered (Jan 2026 already positive) (= BEAT)
- Revenue growth Q-to-Q → delivered 11% growth (= BEAT)
- Gross margin improvement → delivered 7.6% vs 6.1% YoY (= BEAT)
Partly delivered
- Merger/Demerger process → In progress (12-14 month timeline) (= PARTIAL)
Earnings Call filed with BSE, NSE: HEALTHX. Summary written with AI assistance from the document.
Health X Platform Ltd: key numbers
- Share price
- ₹284.15
- Market cap
- ₹903.9 Cr
- Revenue (annual)
- ₹1,319 Cr
- Net profit (annual)
- ₹1.18 Cr
- P/E (TTM)
- -44.8×Sector 53.1×
- Promoter holding
- 74.07%-0.77% QoQ
- FII holding
- 2.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Health X Platform Ltd
All →Health X Platform Other Announcement
Health X Platform Limited dispatched letters to shareholders with unregistered emails, providing web-links for the FY2025-26 Annual Report and 37th AGM notice.
Health X Platform Annual Report
Health X Platform Limited has filed its Annual Report for the financial year 2025-26. The company reported a consolidated total revenue of Rs. 1,319.27 Crore for the period.
Health X Platform Annual General Meeting
Health X Platform Limited will hold its 37th Annual General Meeting on September 28, 2026, via video conferencing. The meeting notice and annual report will be submitted later.
Health X Platform Earnings Call Transcript: Key Takeaways
Health X is aggressively scaling its digital B2B and B2C pharmacy platforms, showing strong top-line momentum while burning cash on technology and geographical expansion.
- Call
- Guides 100% growth
Health X Platform Investor Presentation: Key Takeaways
Health X Platform reports strong Q1 FY27 growth with revenue at ₹440.3 Cr and 7.8% gross margins, leveraging its B2C SastaSundar and B2B Retailer Shakti ecosystems.
- Call
- Guides 30% growth
Health X Platform Management Change
Health X Platform Limited has re-appointed Anjana Dikshit as a Non-Executive Independent Director for a 60-month term, effective November 10, 2026.